++
For further information, see CMDT Part 24-22: Spasticity
+++
Essentials of Diagnosis
++
+++
General Considerations
++
Spasticity is often a major complication of stroke, cerebral or spinal injury, static perinatal encephalopathy, and multiple sclerosis
It may be exacerbated by pressure injuries, urinary or other infections, and nociceptive stimuli
++
A velocity-dependent increase in resistance to passive movement that affects different muscles to a different extent
Not uniform in degree throughout the range of a particular movement
Commonly associated with other features of pyramidal deficit
++
++
Pharmacotherapy is important, but it may increase functional disability when increased extensor tone is providing additional support for patients with weak legs
The following regimens are often helpful
Baclofen, 5–10 mg twice daily orally, titrated up to 80 mg daily as tolerated
Tizanidine, 2–8 mg three time daily orally
Diazepam, 2–10 mg three times daily orally
Dantrolene
Dosage: 25 mg once daily orally, titrated every 3 days as tolerated to a maximum of 100 mg four times daily
Best avoided in patients with poor respiratory function or severe myocardial disease
Cannabinoids are effective in reducing spasticity but are associated with side effects, including dizziness, drowsiness, and fatigue
Intramuscular administration of botulinum toxin has been used to relax targeted muscles
Intrathecal injection of phenol or alcohol may be helpful in severe cases
++
Options include implantation of an intrathecal baclofen pump, rhizotomy, or neurectomy
Severe contractures may be treated by surgical tendon release
++
++
+
Kudva
A
et al. Intrathecal baclofen, selective dorsal rhizotomy, and extracorporeal shockwave therapy for the treatment of spasticity in cerebral palsy: a systematic review. Neurosurg Rev. 2021;44:3209.
[PubMed: 33871733]
+
Palazón-García
R
et al. Botulinum toxin: from poison to possible treatment for spasticity in spinal cord injury. Int J Mol Sci. 2021;22:4886.
[PubMed: 34063051]
+
Ramanathan
RS
et al. Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature. Neurodegener Dis Manag. ...